Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5554 Target Snapshot

Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta · SINGLE PROTEIN · Homo sapiens

740Compounds
211Assays
2Approved Drugs
522.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O00750. Use UniProt O00750 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O00750 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Protein anchor
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta

Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta

Review this target as Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta, mapped to UniProt O00750. Sequence length is 1634 aa.

Protein source · UniProt accession via ChEMBL component mapping
UniProt O00750 Protein 1634 aa
Open protein block
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta as ChEMBL target CHEMBL5554, mapped to UniProt O00750. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5554
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O00750
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta is the right protein anchor across sources, using UniProt O00750 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
UniProt AccessionO00750
Component TypeProtein
Sequence Length1634 aa

Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta, mapped to UniProt O00750. Sequence length is 1634 aa.

Mapped IDO00750
Review namePhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
5
Phase III
10
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50319.0
EC506.0
KD197.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5803247 10.0 Kd 0.1 Preclinical
CHEMBL5894050 9.7 Kd 0.2 Preclinical
CHEMBL5878424 9.7 IC50 0.2 Preclinical
CHEMBL5877033 9.6 IC50 0.251 Preclinical
CHEMBL5831673 9.52 Kd 0.3 Preclinical
CHEMBL3956037 9.4 Kd 0.4 Preclinical
CHEMBL592445 9.34 Kd 0.46 Clinical
CHEMBL5757074 9.3 IC50 0.501 Preclinical
CHEMBL5888478 9.3 Kd 0.5 Preclinical
CHEMBL5268567 9.3 Kd 0.5 Preclinical
Distribution

pChEMBL Value Distribution

15
5.0
12
5.5
53
6.0
18
6.5
15
7.0
21
7.5
35
8.0
53
8.5
19
9.0
4
9.5
pChEMBL
Approved Drugs

Approved Drugs

LAPATINIB
CHEMBL554
Approved 2007
Assay Landscape

Assay Landscape

211
Total Assays
235
Tested Compounds
2
Assay Types
Binding — 210 assays, 235 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 149 172 7.8
assay format 37 36 6.3
cell-based format 18 27 5.6
subcellular format 6 0
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine